Arginine

Arginine

SCHEMBL3633339

CC(N)C(=O)O.N=C(N)NCCCC(N)C(=O)O.NC(CC(=O)O)C(=O)O.NCC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OTC P00480 1/20 0.42
NOS2 P35228 6/20 0.40
NOS1 P29475 5/20 0.40
NOS3 P29474 4/20 0.40
DDAH1 O94760 3/20 0.40
GSR P00390 1/20 0.38
BHMT Q93088 1/20 0.38
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A2 P05177 2/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 1/20 0.35
NOD1 Q9Y239 1/20 0.35
NPY4R P50391 3/20 0.35
NPY1R P25929 2/20 0.35
NPY2R P49146 2/20 0.35
NPY5R Q15761 2/20 0.35
GLA P06280 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL3633342 1.00 OTC (0.42) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL16179489 0.96 OTC (0.44) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL4171389 0.96 OTC (0.44) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL16179227 0.96 OTC (0.44) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL15140178 0.96 OTC (0.44) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL27873762 0.96 OTC (0.44) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL3475256 0.95 OTC (0.39) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL3692892 0.95 OTC (0.39) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL4203993 0.95 OTC (0.46) OTCNOS2NOS1NOS3DDAH1
Arginine SCHEMBL17550 0.95 OTC (0.46) OTCNOS2NOS1NOS3DDAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023170316-A1 HYDROGEL SUITABLE TO PRODUCE ARTIFICIAL TISSUES UNIVERSIDAD DE GRANADA (ES) 2023-09-14 WO disclosed
EP-2150105-A2 SYSTEMS AND METHODS FOR EX-VIVO ORGAN CARE USING LACTATE AS AN INDICATOR Transmedics, Inc. (US) 2010-02-10 EP disclosed
WO-2008150587-A2 SYSTEMS AND METHODS FOR EX-VIVO ORGAN CARE USING LACTATE AS AN INDICATOR TRANSMEDICS, INC. (US) 2008-12-11 WO disclosed